$0.14
0.00 (-0.37%)
Open$0.13
Previous Close$0.14
Day High$0.14
Day Low$0.12
52W High$0.77
52W Low$0.10
Volume—
Avg Volume23.41M
Market Cap55.26M
P/E Ratio—
EPS$-0.44
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+14,929.6% upside
Current
$0.14
$0.14
Target
$20.29
$20.29
$11.90
$20.29 avg
$29.33
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 64.49M | 91.05M | 23.70M |
| Net Income | -200,367,541 | -254,596,621 | -3,056,252 |
| Profit Margin | -310.8% | -295.3% | -12.9% |
| EBITDA | -196,987,738 | -264,207,752 | -4,785,189 |
| Free Cash Flow | — | — | -2,136,953 |
| Rev Growth | -29.2% | -29.2% | +16.7% |
| Debt/Equity | — | — | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $213.76 | +2.08% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $330.33 | -0.13% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $130.28 | -0.17% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $429.32 | -1.15% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $641.69 | +1.81% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.86 | -0.15% | 66.6 | 38.43B |